Registro ESPAMACS. Resumen de actividad 2017-2018

ESPAMACS is the SECTCV's registry for circulatory and respiratory support. It started functioning on 2013 as an evolution of the prior registry from the Grupo de Trabajo de Asistencia Circulatoria. The objective of the current manuscript is presenting a summary of the activity registered. ESPAM...

Descripción completa

Detalles Bibliográficos
Autores: Sandoval, Elena|||0000-0002-4242-5133, Pérez de la Sota, Enrique|||0000-0002-3816-9739, Burgos, Virginia, Osorio, Karina, Tauron, Manel|||0000-0002-5864-519X, Serrano, Santiago, Polo, M.Luz, Carrascal, Yolanda|||0000-0001-6290-5567, Centella, Tomasa, Castillo, Laura, Cuenca, José Joaquín, Barge-Caballero, Eduardo, Padrol, Daniel, Sánchez-Espín, Gemma, Sarralde, José Aurelio
Tipo de recurso: artículo
Fecha de publicación:2019
País:España
Institución:Universitat Autònoma de Barcelona
Repositorio:Dipòsit Digital de Documents de la UAB
Idioma:español
OAI Identifier:oai:ddd.uab.cat:286410
Acceso en línea:https://ddd.uab.cat/record/286410
https://dx.doi.org/urn:doi:10.1016/j.circv.2019.06.005
Access Level:acceso abierto
Palabra clave:Asistencia ventricular
Corta duración
Larga duración
Membrana de oxigenación extracorpórea
Registro
Descripción
Sumario:ESPAMACS is the SECTCV's registry for circulatory and respiratory support. It started functioning on 2013 as an evolution of the prior registry from the Grupo de Trabajo de Asistencia Circulatoria. The objective of the current manuscript is presenting a summary of the activity registered. ESPAMACS is a voluntary registry. Authors have performed a retrospective review of all devices registered between 2017 and 2018. Between 2017-2018, 35 long-term support devices were registered. A number of 378 short-term devices were included in the registry during the same period (303 extracorporeal membrane oxygenation, 30 biventricular assist device, 41 left ventricular assist device y 5 right ventricular assist device). Hospital survival for long-term devices was 80%. Short-term devices present lower rates of survival that varies between 25 and 60%. Long-term devices show a steady increase from previous years. There is a significant increase in the extracorporeal membrane oxygenation implant, for multiple indications. Despite this growing in the number of implants, results remain similar to previous years.

Similares en LA Referencia